Regeneron turns to IT to accelerate drug discovery
CIO Business Intelligence
NOVEMBER 4, 2022
By 2020, IT had moved roughly 60% of all company data to the cloud — no minor task for an international firm that generated $16 billion in revenue in 2021, employs more than 10,000 people, and holds nine FDA- and EMA-approved drugs with an additional 30 in clinical trials. That’s hard to do when you have 30 years of data.”
124 
Let's personalize your content